Danazol treatment and follow-up of patients with endometriosis

Non-randomised trial OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Danazol proved highly effective for treating endometriosis, with side effects generally less severe than other treatments, and a reduced dosage will be tested to further minimize adverse effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In conclusion, we find that danazol has proved to be highly effective as a treatment for endometriosis. On the dosage used, we have not achieved the freedom from side-effects which we had hoped for, but in general these have been much less severe than those with combined oestrogen progestogen preparations. We propose continuing the trial with a reduced dosage of 400 mg daily in the hope of further reducing the incidence of side-effects.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Pelvic Neoplasms Pregnadienes Danazol Danazol Danazol Endometriosis Endometriosis Female Female Follow-Up Studies Follow-Up Studies Humans Humans Pelvic Neoplasms Pelvic Neoplasms Pregnadienes Pregnadienes Pregnancy

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (8)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:16.042305+00:00
License: CC0 · commercial use OK